Jump to content

Publication: Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens

From CAMIH
Revision as of 14:30, 23 August 2024 by Lbordihn (talk | contribs) (Created page with "{{Publication |Title=Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens |Topic=Ginger (also contains zerumbone) |Author=Fahimi, F; Khodadad, K; Amini, S; Naghibi, F; Salamzadeh, J; Baniasadi, S |Year=2011 |Journal=Iranian Journal of Pharmaceutical Research |DOI=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828901/ |Authors Abstract=Ginger, the rhizome of Zingiber officinalis, has long been used as herbal me...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Reference
Title Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens
Topic Ginger (also contains zerumbone)"Ginger (also contains zerumbone)" is not in the list (Aloe vera, Cannabinoids, Curcumin, Enzymes (bromelain papain), Folic acid, Ginkgo, Green tea (EGCG), Low-carbohydrate or ketogenic diet, Lycopene, Selenium, ...) of allowed values for the "Topic" property.
Author Fahimi, F, Khodadad, K, Amini, S, Naghibi, F, Salamzadeh, J, Baniasadi, S
Year 2011
Journal Iranian Journal of Pharmaceutical Research
DOI https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828901/

Author's Abstract The abstract and the information and conclusions contained therein were written by the authors of the publication.

Ginger, the rhizome of Zingiber officinalis, has long been used as herbal medicine for its antiemetic effect. For evaluating the effect of zingiber officinalis on nausea and vomiting (N and V) in patients receiving cisplatin based regimens, a randomized double-blind placebo-controlled cross-over clinical trial was carried out in patients receiving cisplatin in combination with other chemotherapeutic agents. The patients were randomly assigned to receive ginger capsules (rhizome of zingiber officinalis) or placebo in their first cycle of the study. All patients received standard antiemetics for chemotherapy induced nausea and vomiting (CINV). The patients were crossed-over to receive ginger or placebo in their next cycle of chemotherapy. Among 36 eligible patients who received both cycles of treatment, there were no difference in prevalence, severity, and duration of both acute and delayed N and V. Addition of ginger to the standard antiemetic regimen has shown no advantage in reducing acute and delayed N and V in patients with cisplatin-based regimen in this study.



This publication is referenced in the following studies:

  1. Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens